F3131- Children and Parents Affected by Perinatal Substance Use Disorders: Improving Outcomes
Monday, Oct 24, 2016, 3:00 PM - 3:45 PM
Pediatricians, obstetricians, nurses, midwives, and mental health providers in many communities recognize the need for a multidisciplinary approach to in utero drug exposure involving health providers and community members. Several model programs exist.This session will review longstanding programs that address both prenatal care and early intervention within a medical home. Faculty will provide an overview of the epidemiology, pathology, and treatment of in utero drug exposure using approaches for health practitioners and medical and community leadership to facilitate a collaborative approach to ameliorating in utero drug exposure and its sequelae.
Andrew Hsi, MD, MPH, FAAP
Professor of Pediatrics and Family and Community Medicine Director of the Health Sciences Institute for Resilience, Health, and Justice
University of New Mexico Health Sciences Center
Albuquerque, New Mexico
IHS Telebehavioral Health Seminars